Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03446768 · ClinicalTrials.gov registry record · NA
Monitoring and Peer Support to Improve Treatment Adherence and Outcomes
A NA study, sponsored by COPD Foundation.
- Completed
- Registry status
- NA
- Development phase
- 294
- Enrollment target
NCT03446768: Completed NA study, sponsored by COPD Foundation.
NCT03446768 is a NA study that has completed, run by COPD Foundation. The registered enrollment target is 294 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03446768, a NA study, has completed, sponsored by COPD Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 294 participants
- Enrollment target
Study Summary
The O2VERLAP study investigators would like to find out if individuals living with both COPD and OSA would benefit from an online, educational curriculum, coupled with access to peer support (i.e. telephone and online chatting with peers) and remote CPAP adherence monitoring data. The curriculum and peer coaching is meant to provide participants the information and tools they need to be more compliant in using their CPAP device.
Primary Outcome
CPAP adherence is being measured through remote adherence monitoring of all participants; the study inclusion criteria requires all participants be using a CPAP device with wireless modem, the wireless modem allows the study investigators to accurately measure participants CPAP usage daily. Participants CPAP device record the 'total time connected' each day or total time the device is being used (i.e. units are hours per day). Study investigators will retroactively access and collect 30-days of
Interventions
- OTHER Peer support
- OTHER Online platform
- OTHER Respiratory Therapist support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 294 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2019-10-31 |
| Phase | NA |
What the finished NCT03446768 record still lists
NCT03446768 is an interventional study that assigns participants to a tested intervention. The registered 294 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 3 interventions - of which Peer support is the first listed.
NCT03446768 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03446768 about?
NCT03446768 is a clinical study titled "Monitoring and Peer Support to Improve Treatment Adherence and Outcomes". The O2VERLAP study investigators would like to find out if individuals living with both COPD and OSA would benefit from an online, educational curriculum, coupled with access to peer support (i.e. telephone and online chatting with peers) and remote CPAP adherence monitoring data. The curriculum and...
What is the current status of trial NCT03446768?
This trial is currently completed. It is a NA study. The enrollment target is 294 participants. The study started on 2018-02-01. Estimated completion is 2019-10-31.
What interventions are being tested in trial NCT03446768?
The interventions under investigation include: Peer support (OTHER), Online platform (OTHER), Respiratory Therapist support (OTHER).
Who is sponsoring clinical trial NCT03446768?
This trial is sponsored by COPD Foundation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03446768's enrollment target sits among peer trials
294 373rd of 2000 higher than 1,626 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05775159 · 294 participants · Phase 2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
- NCT06262113 · 294 participants · NA
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
- NCT06338865 · 294 participants · NA
Short Title: Standard vs. Lower Pressure Pneumoperitoneum
- NCT06395467 · 294 participants · NA
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI